More than 100 neurologists from 40 states will be on Capitol Hill this week explaining why change is important for specialists and their patients. Medscape Medical News
With ROCKET-AF meeting its primary end point and now being published in the New England Journal of Medicine, the next step for the new oral anticoagulant will be the FDA advisory panel review in September. br / iHeartwire/i
Dr. Hans-Cristoph Diener looks at the impact of evidence-based management protocols in fever, hyperglycemia, and swallowing dysfunction associated with acute stroke. Medscape Neurology
